Clinical trial Recruiting at 1 site Interventional Ages 15 to 40 Women only

Multimodal approach to reduce urinary incontinence in young female athletes

Official title: Effects of a Multimodal and Multidimensional Intervention on Urinary Incontinence in Young Nulliparous Female Athletes. Single-Center Randomized Controlled Stepped-Wedge Trial

Run by Centre Hospitalier Universitaire de Saint Etienne · NCT07644273 · Data updated 2026-11-12

A multimodal program combining pelvic health education and core stability training is tested to see if it reduces urinary incontinence in young nulliparous female athletes.

More Urinary Incontinence trials

Quick facts

Study typeInterventional
Ages15 Years to 40 Years
SexWomen only
Enrollment198 (estimated)
SponsorCentre Hospitalier Universitaire de Saint Etienne
Academic / other
Locations1 site (Saint-Etienne)
StatusRecruiting
StartedSeptember 17, 2026
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedSeptember 30, 2026
Trial IDNCT07644273 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are female athletes who are nulliparous, ages 15–<20/24 depending on category, affiliated with the French Athletics Federation, and have urinary incontinence.

Probably not a fit

Participants who do not respond to the intervention or have conditions interfering with participation may not experience benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial tests a combined pelvic health education and lumbar-pelvic-abdominal stability training program against usual activities. It targets young, nulliparous female athletes affiliated with the French Athletics Federation who experience urinary incontinence. Participants may be adolescents or young adults who have internet and device access and can provide consent with parental permission if under 18. The study aims to provide an evidence-based, sport-specific approach for managing urinary symptoms in this population.

Why it matters

Potential benefit: If successful, participants may experience less urinary leakage and improved athletic confidence and performance.

How similar studies have gone: Past work supports pelvic health and core training for urinary symptoms in general populations, but data in young, nulliparous athletes are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria :

* Female subject, nulliparous
* Member of an athletics club affiliated with the French Athletics Federation (FFA)
* At least 15 years old at the start of the study and belonging to the U16/U18/U20/U23 categories (born between January 1, 2005, and September 1, 2011)
* Having internet access
* Having access to a digital device (computer, tablet, mobile phone)
* Affiliated with or covered by a social security scheme
* Having freely given their express consent, as well as the express consent of both parents for minor participants

Exclusion Criteria :

* Any individual deprived of their liberty or subject to legal protection (guardianship, curatorship, or protective supervision).
* A pregnant woman, a woman who has been pregnant, or a woman planning a pregnancy within the last nine months.
* Any individual unable to understand the purpose and conditions of the study.
* Any individual unable to give their consent.

Where it's running

  • CHU de Saint-Etienne
    Saint-Etienne, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.